![Acute phase of Kawasaki disease: a review of national guideline recommendations. - Abstract - Europe PMC Acute phase of Kawasaki disease: a review of national guideline recommendations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8995165/bin/431_2022_4458_Fig1_HTML.jpg)
Acute phase of Kawasaki disease: a review of national guideline recommendations. - Abstract - Europe PMC
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/68ca0cc8-ba61-4bb5-aa35-b798530f3551/e927fig03.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![S2k‐Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 2: Therapie, Risikofaktoren und spezielle Fragestellungen - Worm - 2021 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library S2k‐Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 2: Therapie, Risikofaktoren und spezielle Fragestellungen - Worm - 2021 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ed27d47d-47c5-42e8-a324-f6f86d09f198/ddg.14491_g.fp.png)
S2k‐Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 2: Therapie, Risikofaktoren und spezielle Fragestellungen - Worm - 2021 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
![Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 | Wiener klinische Wochenschrift Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 | Wiener klinische Wochenschrift](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00508-023-02242-z/MediaObjects/508_2023_2242_Fig8_HTML.png)
Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 | Wiener klinische Wochenschrift
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/351eb4df-2ee9-48ac-8aa4-c7c02f11ab99/e927fig04.jpg)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Chemotherapie | S2k-Leitlinie: Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit | springermedizin.de Chemotherapie | S2k-Leitlinie: Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit | springermedizin.de](https://media.springernature.com/lw150/springer-static/cover/journal/15007/28/5.jpg?as=jpg)
Chemotherapie | S2k-Leitlinie: Diagnostik bei Verdacht auf eine Betalaktamantibiotika-Überempfindlichkeit | springermedizin.de
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/deb18bea-606c-45e0-9485-ea92b4f8efeb/e927tab01.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Juvenile Vaskulitiden | Handlungsempfehlung nach der Leitlinie „Vaskulitiden – Kawasaki-Syndrom“ | springermedizin.de Juvenile Vaskulitiden | Handlungsempfehlung nach der Leitlinie „Vaskulitiden – Kawasaki-Syndrom“ | springermedizin.de](https://media.springernature.com/lw400/springer-static/cover/journal/112/162/5.jpg?as=jpg)
Juvenile Vaskulitiden | Handlungsempfehlung nach der Leitlinie „Vaskulitiden – Kawasaki-Syndrom“ | springermedizin.de
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/89e2a6a1-ff51-47a2-86fe-d310308bb889/e927fig05.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/6f4e7e33-2644-4ea9-b0a8-a46936c85ca4/e927tab11.gif)
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
![Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation](https://www.ahajournals.org/cms/asset/b77f2ed8-5362-4459-8931-34fcfe056ada/e927fig01.jpg)